SI-BONE's iFuse Device Implanted in 25k Patients Worldwide
San Jose, Calif.-based SI-BONE announced more than 8,500 patients have been treated with its iFuse minimally invasive implant system for fusion of the sacroiliac joint. To date, more than 25,000 iFuse implants have been placed in patients worldwide. The device has a triangular-shaped profile that is coated with a porous titanium plasma spray, which allows for biological fixation.
SI-BONE estimates the iFuse Implant System accounts for nearly 90 percent of all minimally invasive SI joint fusion procedures performed in the U.S.
More Articles on Supply Chain:
NuVasive Spine Foundation Raises $230k for Improving Care of Global Patients in Need
Titan Spine Debuts Study Supporting its Device Surface Technology
Medical Device Company DFINE Names Greg Barrett as President, CEO
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New from Becker's ASC Review
Supply Standardization: 7 Ways to Achieve ASC Physician Buy-InRead Now
- 4 Tips for ASCs to Select a Business Analytics System and Streamline Collections
- Business Advisor Relationships: 4 Common Mistakes ASCs Make
- Corporate Compliance Committees: Why Healthcare Facilities Need One
- PriorityOne Launches New Corporate Identity, Moves to Bigger Office
- Online Preoperative Screening Advantages: Q&A With Ambulatory Surgical Center of Stevens Point's Becky Ziegler-Otis